Publications by authors named "J A Puleo"
Background: Total shoulder arthroplasty (TSA) with a nonspherical humeral head component and inlay glenoid is a bone preserving treatment for glenohumeral arthritis. This study aims to describe minimum two year patient reported outcomes, patient acceptable symptomatic state (PASS) achievement, and complications following TSA with this prosthesis.
Methods: A retrospective review of patients undergoing TSA with nonspherical humeral head and inlay glenoid was performed.
Case: We report a case of a lesser tuberosity avulsion fracture in a 14-year-old adolescent boy who presented to Orthopaedic Urgent Care where he was promptly diagnosed after magnetic resonance imaging. The patient was successfully treated with an open transosseous equivalent suture repair 3 weeks after initial injury.
Conclusion: The purpose of this case report was to advance the understanding of these injuries, enable appropriate diagnosis and treatment, and optimize patient's shoulder outcomes and return to sport.
Case: We report a case of an intramuscular thigh hemangioma in a 19-year-old woman with a several year history of atraumatic thigh pain. Radiographs obtained by her primary care physician demonstrated periosteal bone reaction, prompting referral to Orthopaedic Oncology department. The patient had successful symptomatic management with propranolol.
View Article and Find Full Text PDFTotal shoulder arthroplasty with a humeral head resurfacing (HHR) component and an inlay glenoid (OVOMotion; Arthrosurface) is a successful treatment option for patients with advanced glenohumeral arthritis, an intact rotator cuff, and adequate proximal humeral bone stock. In patients with poor proximal humeral bone, historically stemmed humeral components have been used instead of HHR. However, strategies can be used to successfully optimize HHR implant fixation in suboptimal bone without converting to stemmed implants or in surgical centers where stemmed prostheses are not available.
View Article and Find Full Text PDFArticle Synopsis
- - The study examined the effects of starting antiretroviral therapy (ART) during acute or early HIV infection on the viral reservoir and immune responses in participants from various regions.
- - Results showed that starting ART earlier resulted in lower levels of HIV DNA in the blood, particularly for those who began treatment in the very early stages of infection, but it did not fully eliminate the presence of HIV-infected cells.
- - Despite achieving viral suppression at 48 weeks, the study found no strong correlation between HIV DNA levels and the strength of HIV-specific T cell immune responses, suggesting that early treatment may reduce, but not completely prevent, viral rebound after stopping ART.